Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -2473.35% | $ -78.5M | $ 3.17M |
3/31/2025 | -2640.7% | $ -86.35M | $ 3.27M |
12/31/2024 | -2259.92% | $ -89.15M | $ 3.94M |
9/30/2024 | -1577.26% | $ -94.59M | $ 6M |
6/30/2024 | -1173.94% | $ -93.53M | $ 7.97M |
3/31/2024 | -625.4% | $ -86.25M | $ 13.79M |
12/31/2023 | -567.5% | $ -88.13M | $ 15.53M |
9/30/2023 | -517.62% | $ -84.81M | $ 16.39M |
6/30/2023 | -490.89% | $ -84.69M | $ 17.25M |
3/31/2023 | -611.29% | $ -85.94M | $ 14.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for ALIGOS THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -97.83M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -71.54% |
max | 83.41% |
average | 9.03% |
median | 8.77% |
std | 23.72% |